We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 21,965 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/11/2017 07:25 | Lol yep Elric,I'm guessing the initial LP-LDL is Optis DVD player and the one with the LP-GOS modification will be the Blueray offering ; )Sienna | siennadelekat21 | |
19/11/2017 23:15 | warren198219 Nov '17 - 18:18 - 29295 of 29298 0 0 Work out the price for a 90 day supply of benacol it costs more than LP-LDL. Thats because its worth it...and sells!! | rayrac | |
19/11/2017 22:09 | Nope....blueray :) | elrico | |
19/11/2017 21:59 | So were VHS players, until DVD players came along Nimrod22 : ) | siennadelekat21 | |
19/11/2017 18:22 | I think most of us long stayers would be satisfied with the Holy Grail of a pound a share for now! DIAMOND. | diamond fibre | |
19/11/2017 18:18 | Work out the price for a 90 day supply of benacol it costs more than LP-LDL. | warren1982 | |
19/11/2017 17:51 | Benecol is on just about every supermarket shelf in the country; looking at the price charged for it I would assume that its a vast profit maker. | nimrod22 | |
19/11/2017 13:57 | Benacol is dead in the water,comparing it to LP-LDL is like a Morris Minor out dragging a Maserati. GLA. | warren1982 | |
19/11/2017 13:35 | Worry about you uk oil gas ray. Fool. By the way, benecol reduces cholesterol by %? and lpldl by %? I think you will find you have tripped up over you foolish research. Benecol is about to suffer an onslaught from opti products in the not to distant future. | slartybartfaster | |
19/11/2017 12:33 | Salt raises blood pressure, but our gut bacteria can stop it 16/11/17 | parob | |
19/11/2017 12:30 | Rayrac - Benecol reduces more cholesterol than LPLDL? | loungeact | |
19/11/2017 11:29 | Its stress that will kill you Parob, not all down to cholesterol! Stress is what you’ll get with investing in opti! Oh, and Benecol has a better outcome! ;) | rayrac | |
18/11/2017 16:49 | Re Parob's miracle healing: "where are the other nine?" And where are the other swallows? Is not it time some collective results were to hand? But well done Parob on a personal level. I believe the market would like something a little more convincing than the personal account of an enthusiastic investor, eh? | owenmo | |
18/11/2017 16:27 | Parob, that is great news. Very interesting to have these great results with LpLDL working in conjunction with statins. With the promise that LpLDl is to be turned into what is known as an "optibiotic", with a three fold increase in efficacy , it won't be long before you can get rid of the statins altogether! | nicktopten | |
18/11/2017 15:45 | Parob ... LP-LDL plus a lower dose of statins is probably wise considering your family history. I guess most investors though will be hoping LP-LDL will be improved over time to remove the need for any statins at all. From a commercial aspect, given the continued bad press for statins, a product that replaces statins rather than combines is what we need. My results will be ready in around 3-4 weeks. I swapped Simvastatin completely for LP-LDL for a 3 month trial. ODR | onedayrodders | |
18/11/2017 15:25 | Parob - Thanks for sharing your screenshot of the results with me. I'm not familiar with interpreting the data, so took a little time for me to familiarise myself with the readings and check the meaning of them via the NHS site. You simplified it here of course. Your anecdotal evidence certainly underpins what SOH has said about LP-LDL able to support a reduce or maintain a low statins dose, which opens up another commercial opti for LP-LDL. | elrico | |
18/11/2017 13:20 | At some point over the next 12/18 months a lot of people will say they should have bought more during the last 2 years or so. Every anecdotal report we have had has shown our products work for cholesterol reduction. Hopefully, this will be mirrored when we have thousands of people using them. Good times ahead and the wait will have been worth it. | rafboy | |
18/11/2017 12:23 | You can also see the full report, but need to register with capital networks. Id like this bit "We are confident that the current rich deal pipeline will trigger a significant revenue uptake in the coming quarters. Based on our understanding, a typical commercial deal could generate annual revenue in the £250,000 - £500,000 range; we also note that larger deals in the multi-million range are within the Company's current reach" | zebbo | |
18/11/2017 10:53 | Not sure this has been posted before - | loungeact | |
18/11/2017 10:09 | Parob, thanks for the update and some great results!! It might not be a part of a big trial but I may have heard somewhere that every little helps :-) | 1bokke | |
18/11/2017 10:04 | That's a great personal update Parob. Great too, that many of us have a genuine reason for wanting Opti to come come good, quite apart from the financial benefits to come too. Oh, and hopefully potential financial savings for our NHS down the line, As others have said "What's not to like?". John | 2350220 | |
18/11/2017 08:32 | Well, Parob. If nothing else your results should give us all an extra couple of pence Monday. | aspex | |
17/11/2017 23:03 | Well when Opti get their lpldl on sale on a decent scale they should be able to capitalise on that Daily Express headline. I expect to buy in again at the back end of next week at around 66/67. If no news released then I think that's probable. | imnotlong |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions